Table 1. Overall study design.
| Screening | Allocation | Before dosing | Dosing (1st, 2nd, and 3rd term) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.0 h | 0.5 h | 1 h | 2 h | 4 h | 8 h | 12 h | 24 h | ||||
| Informed consent | ● | ||||||||||
| Background survey | ● | ||||||||||
| Medical examination | ● | ● | ● | ● | |||||||
| Physical examination | ● | ● | |||||||||
| Vital sign measurement | ● | ● | ● | ● | ● | ||||||
| Blood test | ● | ● | ● | ||||||||
| Blood draw | ● | ● | ● | ● | ● | ● | ● | ● | |||
| Urine test | ● | ||||||||||
| Behavior recording | <---- | ----- | ----- | ----- | ----- | ----- | ----- | ----> | |||
| Meal | ● | ● | |||||||||